Patents by Inventor C. Hodges

C. Hodges has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140170867
    Abstract: The present application provides a connection device and a connector. The connector comprises a housing mounted on a circuit substrate and a plurality of terminals. The housing has a recessed region and a plurality of channels. The recessed region, together with the circuit substrate, forms a mating groove for mating a flexible circuit board, and the mating groove extends forwardly to a radius. The plurality of terminals correspond to the plurality of channels and each of the terminal includes a resilient contact arm. The resilient contact arm extends toward a surface of the circuit substrate in the corresponding channel of the housing and extends into the recessed region to form a contact portion. The connection device comprises the circuit substrate and the connector.
    Type: Application
    Filed: September 12, 2013
    Publication date: June 19, 2014
    Applicant: Molex Incorporated
    Inventor: Ronald C. Hodge
  • Publication number: 20140072713
    Abstract: A method for creating new educational, and theme party products in the form of full color 3D paper napkin entities that resemble the color image likeness the entity that the napkin fold or origami fold is named for. By combining color napkin or origami patterns applied to the art or industry medium of square paper napkins or serviettes with the intention of matching the pattern to the like named fold or origami fold, creates a fun challenge to the individual folder to achieve the correct folded outcome. The paper napkins are both functional for everyday use, and are folding fun for seasonal & theme parties, birthdays, and are educational as they stimulate conversation and the creative mind while folding.
    Type: Application
    Filed: August 30, 2013
    Publication date: March 13, 2014
    Inventor: John C. Hodges
  • Publication number: 20140060525
    Abstract: The present invention provides novel condensation aerosols for the treatment of disease and/or intermittent or acute conditions. These condensation aerosols have little or no pyrolysis degradation products and are characterized by having an MMAD of between 1-3 microns. These aerosols are made by rapidly heating a substrate coated with a thin film of drug having a thickness of between 0.05 and 20 ?m, while passing a gas over the film, to form particles of a desirable particle size for inhalation. Kits comprising a drug and a device for producing a condensation aerosol are also provided. The device contained in the kit typically, has an element for heating the drug which is coated as a film on the substrate and contains a therapeutically effective dose of a drug when the drug is administered in aerosol form, and an element allowing the vapor to cool to form an aerosol. Also disclosed, are methods for using these aerosols and kits.
    Type: Application
    Filed: November 13, 2013
    Publication date: March 6, 2014
    Applicant: Alexza Pharmaceuticals, Inc.
    Inventors: Ron L. Hale, Craig C. Hodges, Peter M. Lloyd, Amy T. Lu, Daniel J. Myers, Joshua D. Rabinowitz, Martin J. Wensley, Jeffrey A. McKinney, Alejandro C. Zaffaroni
  • Publication number: 20140060532
    Abstract: The present invention relates to the inhalation delivery of aerosols containing small particles. Specifically, it relates to a device that forms drug containing aerosols for use in inhalation therapy. In a device aspect of the present invention, a device for delivering drug containing aerosols for inhalation therapy is provided. The device includes a housing and an airway that has a gas/vapor mixing airway. The airway further includes a subassembly, which has a metallic substrate coated on its surface with a composition comprising a drug.
    Type: Application
    Filed: November 13, 2013
    Publication date: March 6, 2014
    Applicant: Alexza Pharmaceuticals, Inc.
    Inventors: Craig C. Hodges, Peter M. Lloyd, Daniel Mufson, Daniel D. Rogers, Martin J. Wensley
  • Publication number: 20140066618
    Abstract: The present invention relates to the inhalation delivery of aerosols containing small particles. Specifically, it relates to a method of forming an aerosol for use in inhalation therapy. The method involves: (a) heating a substrate coated with a composition comprising a drug to form a vapor, wherein the coated composition is in the form of a film less than 10 ?thick; and, (b) allowing the vapor to cool, thereby forming an aerosol, which is used in inhalation therapy. In another aspect, a method of forming an aerosol for use in inhalation therapy is provided, wherein the method comprises: (a) heating a substrate coated with a composition comprising a drug to form a vapor in less than 100 milliseconds, wherein the vapor has a mass greater than 0.
    Type: Application
    Filed: November 11, 2013
    Publication date: March 6, 2014
    Inventors: Ron L. Hale, Craig C. Hodges, Peter M. Lloyd, Daniel Mufson, Daniel D. Rogers, Soonho Song, Martin J. Wensley, Daniel J. Myers, Jeffrey A. McKinney, Reynaldo J. Quintana, Joshua D. Rabinowitz
  • Publication number: 20130276779
    Abstract: The present invention relates to the inhalation delivery of aerosols containing small particles. Specifically, it relates to a method of forming an aerosol for use in inhalation therapy. The method involves: (a) heating a substrate coated with a composition comprising a drug to form a vapor, wherein the coated composition is in the form of a film less than 10? thick; and, (b) allowing the vapor to cool, thereby forming an aerosol, which is used in inhalation therapy. In another aspect, a method of forming an aerosol for use in inhalation therapy is provided, wherein the method comprises: (a) heating a substrate coated with a composition comprising a drug to form a vapor in less than 100 milliseconds, wherein the vapor has a mass greater than 0.
    Type: Application
    Filed: March 27, 2013
    Publication date: October 24, 2013
    Inventors: Ron L. Hale, Craig C. Hodges, Peter M. Lloyd, Daniel Mufson, Daniel D. Rogers, Soonho Song, Martin J. Wensley, Daniel J. Myers, Jeffrey A. McKinney, Reynaldo J. Quintana, Joshua D. Rabinowitz
  • Publication number: 20130244465
    Abstract: A receptacle connector includes an insulative body, conductive terminals mounted therein, and a seal covering a central portion of the body. The receptacle connector mates with at least one mating electrical connector. The seal prevents the intrusion of dust into the joint between the receptacle connector and the mating electrical connector(s). The seal and the body have locking features provided thereon to secure the seal to the housing.
    Type: Application
    Filed: September 30, 2010
    Publication date: September 19, 2013
    Applicant: Molex Incorporated
    Inventor: Ronald C. Hodge
  • Publication number: 20130032139
    Abstract: The present invention provides novel condensation aerosols for the treatment of disease and/or intermittent or acute conditions. These condensation aerosols have little or no pyrolysis degradation products and are characterized by having an MMAD of between 1-3 microns. These aerosols are made by rapidly heating a substrate coated with a thin film of drug having a thickness of between 0.05 and 20 ?m, while passing a gas over the film, to form particles of a desirable particle size for inhalation. Kits comprising a drug and a device for producing a condensation aerosol are also provided, wherein the device, has an element for heating the drug which is coated as a film on the substrate and contains a therapeutically effective dose of a drug when the drug is administered in aerosol form, and an element allowing the vapor to cool to form an aerosol. Methods for use are also disclosed.
    Type: Application
    Filed: August 7, 2012
    Publication date: February 7, 2013
    Applicant: ALEXZA PHARMACEUTICALS, INC.
    Inventors: Ron L. Hale, Craig C. Hodges, Peter M. Lloyd, Amy T. Lu, Daniel J. Myers, Joshua D. Rabinowitz, Martin J. Wensley, Jeffrey A. McKinney, Alejandro C. Zaffaroni
  • Patent number: 8235037
    Abstract: The present invention provides novel condensation aerosols for the treatment of disease and/or intermittent or acute conditions. These condensation aerosols have little or no pyrolysis degradation products and are characterized by having an MMAD of between 1-3 microns. These aerosols are made by rapidly heating a substrate coated with a thin film of drug having a thickness of between 0.05 and 20 ?m, while passing a gas over the film, to form particles of a desirable particle size for inhalation. Kits comprising a drug and a device for producing a condensation aerosol are also provided. The device contained in the kit typically, has an element for heating the drug which is coated as a film on the substrate and contains a therapeutically effective dose of a drug when the drug is administered in aerosol form, and an element allowing the vapor to cool to form an aerosol. Also disclosed, are methods for using these aerosols and kits.
    Type: Grant
    Filed: May 8, 2008
    Date of Patent: August 7, 2012
    Assignee: Alexza Pharmaceuticals, Inc.
    Inventors: Ron L. Hale, Craig C. Hodges, Peter M. Lloyd, Amy T. Lu, Daniel J. Myers, Joshua D. Rabinowitz, Martin J. Wensley, Jeffrey A. McKinney, Alejandro C. Zaffaroni
  • Patent number: 8198290
    Abstract: The present invention provides for compounds of Formula I and II: wherein y, X, Y, Z, R1, and R2 have any of the values defined there for in the specification. The compounds of formula I are useful as reagents in the isolation and the assay of PQQ dependent enzymes. Also provided are compositions comprising compounds of Formula I and II.
    Type: Grant
    Filed: December 23, 2009
    Date of Patent: June 12, 2012
    Assignee: Berry and Associates, Inc.
    Inventor: John C. Hodges
  • Publication number: 20120142908
    Abstract: The present invention provides for compounds of Formula I: wherein X—N and R1-R4 have any of the values disclosed in the specification. The compounds of Formula I are useful as reagents to introduce N-alkyl nucleosides into DNA oligonucleotides. The present invention also provides for methods of synthesizing the compounds of Formula I.
    Type: Application
    Filed: November 29, 2011
    Publication date: June 7, 2012
    Applicant: Berry and Associates, Inc.
    Inventors: David A. Berry, Lana L. Berry, John C. Hodges
  • Patent number: 8074644
    Abstract: The present invention relates to the inhalation delivery of aerosols containing small particles. Specifically, it relates to a method of forming an aerosol for use in inhalation therapy. In a method aspect of the present invention, a method of forming an aerosol for use in inhalation therapy is provided. The method involves the following steps: (a) heating a substrate coated with a composition comprising a drug at a rate greater than 1000° C./s, thereby forming an vapor; and, (b) allowing the vapor to cool, thereby forming an aerosol, which is used in inhalation therapy. In another method aspect of the present invention, a method of forming an aerosol for use in inhalation therapy is provided. The method involves the following steps: (a) heating a substrate coated with a composition comprising a drug to form a vapor, wherein the coated composition is in the form of a film less than 10? thick; and, (b) allowing the vapor to cool, thereby forming an aerosol, which is used in inhalation therapy.
    Type: Grant
    Filed: May 22, 2009
    Date of Patent: December 13, 2011
    Assignee: Alexza Pharmaceuticals, Inc.
    Inventors: Ron L. Hale, Craig C. Hodges, Peter M. Lloyd, Daniel Mufson, Daniel D. Rogers, Soonho Song, Martin J. Wensley, Daniel J. Myers, Jeffrey A. McKinney, Reynaldo J. Quintana, Joshua D. Rabinowitz
  • Publication number: 20110240022
    Abstract: The present invention relates to the inhalation delivery of aerosols containing small particles. Specifically, it relates to a device that forms drug containing aerosols for use in inhalation therapy. In a device aspect of the present invention, a device for delivering drug containing aerosols for inhalation therapy is provided. The device includes a housing and an airway that has a gas/vapor mixing airway. The airway further includes a subassembly, which has a metallic substrate coated on its surface with a composition comprising a drug.
    Type: Application
    Filed: April 1, 2011
    Publication date: October 6, 2011
    Applicant: ALEXZA PHARMACEUTICALS, INC.
    Inventors: Craig C. Hodges, Peter M. Lloyd, Daniel Mufson, Daniel D. Rogers, Martin J. Wensley
  • Publication number: 20110244020
    Abstract: The present invention provides novel condensation aerosols for the treatment of disease and/or intermittent or acute conditions. These condensation aerosols have little or no pyrolysis degradation products and are characterized by having an MMAD of between 1-3 microns. These aerosols are made by rapidly heating a substrate coated with a thin film of drug having a thickness of between 0.05 and 20 ?m, while passing a gas over the film, to form particles of a desirable particle size for inhalation. Kits comprising a drug and a device for producing a condensation aerosol are also provided. The device contained in the kit typically, has an element for heating the drug which is coated as a film on the substrate and contains a therapeutically effective dose of a drug when the drug is administered in aerosol form, and an element allowing the vapor to cool to form an aerosol. Also disclosed, are methods for using these aerosols and kits.
    Type: Application
    Filed: April 1, 2011
    Publication date: October 6, 2011
    Applicant: Alexza Pharmaceuticals, Inc.
    Inventors: Ron L. HALE, Craig C. Hodges, Peter M. Lloyd, Amy T. Lu, Daniel J. Myers, Joshua D. Rabinowitz, Martin J. Wensley, Jeffrey A. McKinney, Alejandro C. Zaffaroni
  • Publication number: 20110240013
    Abstract: The present invention relates to the inhalation delivery of aerosols containing small particles. Specifically, it relates to a method of forming an aerosol for use in inhalation therapy. In a method aspect of the present invention, a method of forming an aerosol for use in inhalation therapy is provided. The method involves the following steps: (a) heating a substrate coated with a composition comprising a drug at a rate greater than 1000° C./s, thereby forming a vapor; and, (b) allowing the vapor to cool, thereby forming an aerosol, which is used in inhalation therapy. In another method aspect of the present invention, a method of forming an aerosol for use in inhalation therapy is provided. The method involves the following steps: (a) heating a substrate coated with a composition comprising a drug to form a vapor, wherein the coated composition is in the form of a film less than 10? thick; and, (b) allowing the vapor to cool, thereby forming an aerosol, which is used in inhalation therapy.
    Type: Application
    Filed: April 1, 2011
    Publication date: October 6, 2011
    Applicant: ALEXZA PHARMACEUTICALS, INC.
    Inventors: Ron L. Hale, Craig C. Hodges, Peter M. Lloyd, Daniel Mufson, Daniel D. Rogers, Soonho Song, Martin J. Wensley, Daniel J. Myers, Jeffrey A. McKinney, Reynaldo J. Quintana, Joshua D. Rabinowitz
  • Publication number: 20110152526
    Abstract: The present invention provides for compounds of Formula I and II: wherein y, X, Y, Z, R1, and R2 have any of the values defined there for in the specification. The compounds of formula I are useful as reagents in the isolation and the assay of PQQ dependent enzymes. Also provided are compositions comprising compounds of Formula I and II.
    Type: Application
    Filed: December 23, 2009
    Publication date: June 23, 2011
    Applicant: Berry and associates, Inc.
    Inventor: John C. Hodges
  • Patent number: 7960526
    Abstract: The present invention provides for reagents for the introduction of colorimetric-oxycarbonyl protecting groups, compounds bearing colorimetric-oxycarbonyl protecting groups, and the use thereof in solid-supported organic syntheses of oligonucleotides, polypeptides, polysaccharides, and combinatorial libraries.
    Type: Grant
    Filed: March 30, 2009
    Date of Patent: June 14, 2011
    Assignee: Berry and Associates, Inc.
    Inventors: John C. Hodges, Yam Foo Poon, William H. Pearson
  • Patent number: 7942147
    Abstract: The present invention relates to the inhalation delivery of aerosols containing small particles. Specifically, it relates to a device that forms drug containing aerosols for use in inhalation therapy. In a device aspect of the present invention, a device for delivering drug containing aerosols for inhalation therapy is provided. The device includes a housing and an airway that has a gas/vapor mixing airway. The airway further includes a subassembly, which has a metallic substrate coated on its surface with a composition comprising a drug.
    Type: Grant
    Filed: May 13, 2002
    Date of Patent: May 17, 2011
    Assignee: Alexza Pharmaceuticals, Inc.
    Inventors: Craig C. Hodges, Peter M. Lloyd, Daniel Mufson, Daniel D. Rogers, Martin J. Wensley
  • Patent number: 7913688
    Abstract: A device for delivering a drug by inhalation is disclosed. The device includes a body defining an interior flow-through chamber having upstream and downstream chamber openings, and a drug supply unit contained within the chamber for producing, upon actuation, a heated drug vapor in a condensation region of the chamber. Gas drawn through the chamber region at a selected gas-flow rate is effective to form drug condensation particles from the drug vapor having a selected MMAD between 0.02 and 0.1 MMAD or between 1 and 3.5 ?m. A gas-flow control valve disposed upstream of the unit functions to limit gas-flow rate through the condensation region to the selected gas-flow rate. An actuation switch in the device activates the drug-supply unit, such that the drug-supply unit can be controlled to produce vapor when the gas-flow rate through the chamber is at the selected flow rate.
    Type: Grant
    Filed: May 20, 2003
    Date of Patent: March 29, 2011
    Assignee: Alexza Pharmaceuticals, Inc.
    Inventors: Stephen Cross, Craig C. Hodges, Ron L. Hale, Peter M. Lloyd, Daniel J. Myers, Reynaldo J. Quintana, Joshua D. Rabinowitz, Curtis Tom, Martin J. Wensley
  • Patent number: D651567
    Type: Grant
    Filed: September 30, 2010
    Date of Patent: January 3, 2012
    Assignee: Molex Incorporated
    Inventor: Ronald C. Hodge